8 RESEARCH CENTERS

Led by Renowned Scientists and Dedicated to Advancing Scientific Discovery

CENTERS OF EXCELLENCE

A select number of academic programs earn the designation as a Center of Excellence by the Louisiana Board of Regents and must demonstrate statewide leadership in their area of focus and a commitment to building on their respective strengths by advancing knowledge and skills to create better opportunities for improving the quality of life of Louisiana residents. Designated centers share being a hallmark of the institution with a strong performance record, concentration in a clearly defined area relevant to the state’s needs, a range of academic, training and research opportunities, and engagement with the greater community to address current issues. LSU Health Shreveport is home to four designated Centers of Research Excellence.

Feist-Weiller Cancer Center

FWCC icon

The Feist-Weiller Cancer Center team is committed to bringing life-saving discoveries about cancer to all of Louisiana and beyond. Collaboration between cancer researchers and treating physicians fosters a more comprehensive understanding of cancer.

Learn More

Center of Excellence for Arthritis and Rheumatology

CEAR icon

The Center engages in a multidisciplinary clinical, research and education mission to provide patients with cutting-edge care, advance the science of inflammatory and immunology diseases and to educate physicians.

Learn More

Center for Cardiovascular Diseases and Sciences

CCDS icon

The Center's mission is to advance the understanding of cardiovascular disease and translational research while developing future generations of basic and clinical science investigators.

Learn More

Center for Emerging Viral Threats

cevt icon

The Center intersects critical public health needs with timely delivery of clinical and vaccine trials, testing, key SARS-CoV2 and other pathogen clinical diagnosis, community education, and training scientists, physicians and health work force.

Learn More

TEACH • HEAL • DISCOVER

Center for Brain Health

cbh icon

The Center for Brain Health expands neuroscience-related education, provides comprehensive care for brain disorders, and attracts young specialists and pioneering clinical trials to North Louisiana, and competes for large scale research funding.

Learn More

Louisiana Addiction Research Center

larc icon

LARC is committed to increasing knowledge and advancing research related to Substance Use Disorders to create a better quality of life for the citizens of our area.

 

Learn More

Center of Academic Excellence for Patient Centered Rehabilitation

The School of Allied Health Professions' Center (CAE-PaCeR) will establish an infrastructure to bring the relevant academic, research, and clinical programs of the School into alignment for clinical learning, innovation, and collaboration.

Learn More

Centers of Biomedical Research Excellence

In addition to the six Louisiana Board of Regents and LSU Board of Supervisors approved Centers, LSU Health Shreveport has two National Institutes of Health (NIH) Centers of Biomedical Research Excellence (COBRE). The Centers of Biomedical Research Excellence (COBRE) awards support the establishment and development of innovative, state-of-the-art biomedical and behavioral research centers at institutions in IDeA-eligible states through awards for three sequential five-year phases.

Center for Applied Immunology and Pathological Processes

The Center for Applied Immunology and Pathological Processes, directed by Dr. Andrew Yurochko, was established In 2021, supported by a five year, $10.5 million grant from the NIH.

 Learn More

Center for Redox Biology and Cardiovascular Disease

The Center for Redox Biology and Cardiovascular Disease, directed by Dr. Chris Kevil, was established in 2018 and is supported by a five-year, $10.5 million NIH COBRE grant.
 

Learn More

Our Centers are actively engaged in educating the community,
training future scientists and advancing research through active collaborations.

    

Latest Research Centers News

KEEL Radio News - LSU Health Shreveport starts two promising COVID Clinical Trials - image of scientist in the lab

LSU Health Shreveport / Feist-Weiller Cancer Center is a strategic partner with MD Anderson and the Cancer Focus Fund LP working to advance promising cancer therapies.

Read More about March Biosciences and Cancer Focus Fund Announce $4.8 Million Investment to Support a Phase 2 Clinical Trial of Novel CAR-T Therapy for T-Cell Lymphoma (opens in new window/tab)
Biomedical Research and Industry Day 2023: “Training Today’s Scientist for Tomorrow’s Benefit”

“BRAID is more than just a conference, it’s a vibrant ecosystem of ideas fostering innovation among students, scientists and clinicians,” said Wayne Nix, chief innovation officer at LSUHS. “We celebrate the great minds of academia and industry brought together for a collaborative effort from all of our partners."

 

Read More about Biomedical Research and Industry Day 2023: “Training Today’s Scientist for Tomorrow’s Benefit”
Dr. Gary Burton instructs staff at Feist-Weiller Cancer Center

Feist-Weiller Cancer Center, a Center of Excellence in Cancer Research, Treatment and Education at LSUHS and Loxo@Lilly, the oncology unit of Eli Lilly and Company, recently launched a new research collaboration that will provide next-generation sequencing (NGS) access to underserved cancer patients in the northern Louisiana region.

Read More about LSUHS, Loxo@Lilly Partner to Study Impact of Next-Generation Sequencing on Cancer Treatment Decisions and Patient Outcomes
three women in a lab

The Center for Emerging Viral Threats at LSUHS recently sequenced the first instances in Louisiana of the XBB.1.16 and XBB.1.9.1 variants. "Detecting these very recently emerging variants demonstrates the robustness of our efforts,” said Krista Queen, PhD, Director of Viral Genomics and Surveillance.

Read More about CEVT Continues to Expand Viral Sequencing Efforts, Sequences Two Omicron Subvariants Becoming More Prevalent in the U.S.
The Center for Cardiovascular Diseases and Sciences works throughout the year to advance cardiovascular research

Shreveport Times - Dr. Wayne Orr, Professor and Director of the Center for Cardiovascular Diseases and Sciences said, "the Center is a group of faculty members across multiple departments who work together to build a nationally competitive research group here in Shreveport."

Read More about The Center for Cardiovascular Diseases and Sciences works throughout the year to advance cardiovascular research (opens in new window/tab)
LSUHS LARC hosts meeting on the threat of Methamphetamine use in Northwest Louisiana

LSUHS Louisiana Addiction Research Center hosted a meeting on Wednesday, Nov. 9, to discuss methamphetamine as an emerging drug threat in our region. Local law enforcement and community leaders were invited to have an open conversation and share information on drug problems in the region and determine how to raise awareness.

Read More about LSUHS LARC hosts meeting on the threat of Methamphetamine use in Northwest Louisiana
two scientists in lab

The Louisiana Board of Regents has supported full five-year approval for the Louisiana Addiction Research Center (LARC) and Center for Emerging Viral Threats (CEVT), with the CEVT continuing to be a designated Center of Research Excellence. The Board of Regents approval follows unanimous approval of both centers by the LSU Board of Supervisors earlier this year. Both centers were previously granted provisional approval and applied for full center approval earlier this year.

Read More about LSUHS Research Centers Receive Full Authorization from LSU Board of Supervisors and Louisiana Board of Regents
Center For Emerging Viral Threats  Reaches Milestone Of Sharing 15,000 Sars-Cov-2 Sequences To Global Database

The Center of Excellence for Emerging Viral Threats’ (CEVT) Viral Genomics and Surveillance Lab has surpassed uploading its’ 15,000th sequence to GISAID (Global Initiative on Sharing Influenza Data). The LSU Health Shreveport CEVT team has worked tirelessly since early in the COVID-19 pandemic to sequence and track variants of SAR-CoV-2, the virus that causes the COVID-19 disease.

Read More about Center For Emerging Viral Threats Reaches Milestone Of Sharing 15,000 Sars-Cov-2 Sequences To Global Database
Research captures unfolding cardiovascular toll from meth use

A massive new study spotlights the toll methamphetamine use may take on heart health, suggesting men, people with kidney disease and those with high blood pressure are especially at risk. While researchers don't fully understand how meth use increases the risk for heart problems, they do know it creates a lot of stress on the body, shared Dr. Chris Kevil, LSUHS Vice Chancellor for Research.

Read More about Research captures unfolding cardiovascular toll from meth use (opens in new window/tab)
Photo of Center of Brain Health team viewing screens of brain for evaluation

Our Centers

We Teach. We Heal. We Discover.